Ligand validation:6OFY

BOG: octyl beta-D-glucopyranoside

BOG is a Ligand Of Interest in 6OFY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OFY_BOG_A_606	71%	44%	0.12	0.942	0.98	1.18	1	2	0	0	100%	1
3HS6_BOG_A_703	93%	70%	0.065	0.958	0.45	0.69	-	-	0	0	100%	0.5
3MQE_BOG_A_704	90%	70%	0.073	0.955	0.55	0.6	-	-	0	0	100%	1
3RR3_BOG_A_3	90%	26%	0.079	0.96	1.47	1.51	5	6	5	0	100%	1
4PH9_BOG_A_603	85%	46%	0.08	0.945	0.89	1.17	1	1	1	0	100%	1
4Z0L_BOG_A_708	82%	45%	0.094	0.948	1.06	1.07	1	2	0	0	100%	1
2R4J_BOG_B_700	99%	50%	0.047	0.987	0.82	1.09	1	2	2	0	100%	1
5B5S_BOG_A_301	99%	45%	0.045	0.983	0.92	1.19	1	1	0	0	100%	1
4KRG_BOG_A_503	99%	54%	0.048	0.981	1.11	0.69	2	-	1	0	100%	1
2OXL_BOG_B_101	96%	29%	0.064	0.97	1.1	1.71	2	5	1	1	100%	0.7
7VL5_BOG_A_801	93%	65%	0.072	0.967	0.73	0.63	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.